Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The primary objective of this study is to assess the safety and efficacy of the Celution Device in the processing of an autologous graft consisting of adipose derived regenerative cells (ADRCs) in the treatment of hand dysfunction due to scleroderma.
Epistemonikos ID: ad8a6661bdcedab38fba909d7457abaea1391eab
First added on: May 12, 2024